← Back to directory

Boris Schmitz

Researcher Next ID · RN-032198

Researcher · Biochemistry, Genetics and Molecular Biology

Witten/Herdecke University

Witten, Germany

Accepting doctoral researchersFunding unknown
Works count
1,388
Citation count
2,039
H-index
27
i10-index
58

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Exercise and Physiological Responses
Cardiovascular and exercise physiology
Physical Activity and Health
Cardiovascular Effects of Exercise
Genetics and Physical Performance

Publications

  • Autonomic dysregulation in long-term patients suffering from Post-COVID-19 Syndrome assessed by heart rate variability

    Scientific Reports · 2023 · 10.1038/s41598-023-42615-y

  • Medical Rehabilitation of Patients with Post-COVID-19 Syndrome—A Comparison of Aerobic Interval and Continuous Training

    Journal of Clinical Medicine · 2023 · 10.3390/jcm12216739

  • Prognostic and therapeutic potential of microRNAs for fracture healing processes and non‐union fractures: A systematic review

    Clinical and Translational Medicine · 2023 · 10.1002/ctm2.1161

  • Non-coding RNAs in exercise immunology: A systematic review

    Journal of sport and health science/Journal of Sport and Health Science · 2023 · 10.1016/j.jshs.2023.11.001

  • eHealth for maintenance cardiovascular rehabilitation: a systematic review and meta-analysis

    European Journal of Preventive Cardiology · 2023 · 10.1093/eurjpc/zwad145

  • Therapeutic Potential of Electromyostimulation (EMS) in Critically Ill Patients—A Systematic Review

    Frontiers in Physiology · 2022 · 10.3389/fphys.2022.865437

  • Four weeks of electromyostimulation improves muscle function and strength in sarcopenic patients: a three‐arm parallel randomized trial

    Journal of Cachexia Sarcopenia and Muscle · 2021 · 10.1002/jcsm.12717

  • Sex Differences in High-Intensity Interval Training–Are HIIT Protocols Interchangeable Between Females and Males?

    Frontiers in Physiology · 2020 · 10.3389/fphys.2020.00038

  • Mutation-specific Fabry disease patient-derived cell model to evaluate the amenability to chaperone therapy

    Journal of Medical Genetics · 2019 · 10.1136/jmedgenet-2019-106005

  • Effects of high-intensity interval training on microvascular glycocalyx and associated microRNAs

    American Journal of Physiology-Heart and Circulatory Physiology · 2019 · 10.1152/ajpheart.00751.2018

  • Neutralising anti‐drug antibodies in Fabry disease can inhibit endothelial enzyme uptake and activity

    Journal of Inherited Metabolic Disease · 2019 · 10.1002/jimd.12176

  • Effects of high-intensity interval training on optic nerve head and macular perfusion using optical coherence tomography angiography in healthy adults

    Atherosclerosis · 2018 · 10.1016/j.atherosclerosis.2018.04.028

  • The Yo-Yo Intermittent Tests: A Systematic Review and Structured Compendium of Test Results

    Frontiers in Physiology · 2018 · 10.3389/fphys.2018.00870

  • Dose-Dependent Effect of Enzyme Replacement Therapy on Neutralizing Antidrug Antibody Titers and Clinical Outcome in Patients with Fabry Disease

    Journal of the American Society of Nephrology · 2018 · 10.1681/asn.2018070740

  • Characterization of drug-neutralizing antibodies in patients with Fabry disease during infusion

    Journal of Allergy and Clinical Immunology · 2018 · 10.1016/j.jaci.2017.12.1001

  • Longer Work/Rest Intervals During High-Intensity Interval Training (HIIT) Lead to Elevated Levels of miR-222 and miR-29c

    Frontiers in Physiology · 2018 · 10.3389/fphys.2018.00395

  • Promoter methylation inhibits expression of tumor suppressor KIBRA in human clear cell renal cell carcinoma

    Clinical Epigenetics · 2017 · 10.1186/s13148-017-0415-6

  • Two-year outcome and risk factors for mortality in patients with coronary artery disease and renal failure: The prospective, observational CAD-REF Registry

    International Journal of Cardiology · 2017 · 10.1016/j.ijcard.2017.05.022

  • Impact of immunosuppressive therapy on therapy‐neutralizing antibodies in transplanted patients with Fabry disease

    Journal of Internal Medicine · 2017 · 10.1111/joim.12647

  • Dose-Response of High-Intensity Training (HIT) on Atheroprotective miRNA-126 Levels

    Frontiers in Physiology · 2017 · 10.3389/fphys.2017.00349

  • Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant

    Orphanet Journal of Rare Diseases · 2016 · 10.1186/s13023-016-0441-z

  • Thromboembolic events in Fabry disease and the impact of factor V Leiden

    Neurology · 2015 · 10.1212/wnl.0000000000001333

  • Serum-Mediated Inhibition of Enzyme Replacement Therapy in Fabry Disease

    Journal of the American Society of Nephrology · 2015 · 10.1681/asn.2014121226

  • Salt controls endothelial and vascular phenotype

    Pflügers Archiv - European Journal of Physiology · 2014 · 10.1007/s00424-014-1657-1

  • Multifocal White Matter Lesions Associated with the D313Y Mutation of the α-Galactosidase A Gene

    PLoS ONE · 2013 · 10.1371/journal.pone.0055565

Current projects

    No projects listed.